Hello, everyone, and how are you this fine morning? A warm and shiny sun is enveloping the peacefully quiet Pharmalot campus, where we have only the official mascot to keep us company. And since our pooch spends most of the day snoozing, we have fewer distractions as we forage for interesting items. Moments to cherish, yes? On that note, we happily offer the latest menu of tidbits to help you on your journey today. Hope all goes well and you conquer the world. And as always, we invite you to keep in touch. We accept tips and dossiers. …

In an unusual move, House Republicans are warning drug makers against complying with a House investigation into drug prices, BuzzFeed News reports. Republicans on the House Oversight Committee sent letters to a dozen chief executives, warning that information they provide to the committee could be leaked to the public by Democratic chair Elijah Cummings in an effort to tank their stock prices. Politicians routinely spar over committee work, but Democrats say warning companies not to comply with an investigation is unconventional — perhaps unprecedented.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy